Ankyloglossia, or tongue-tie, is a congenital anomaly characterized by a shortened lingual frenulum that may cause restricted tongue mobility resulting in several functional limitations.^[@bibr1-2473974X19826943][@bibr2-2473974X19826943]-[@bibr3-2473974X19826943]^ Children can present with difficulties with feeding, speech, articulation, and swallowing.^[@bibr4-2473974X19826943]^ Ankyloglossia is typically treated with surgical division of the frenulum with closure (frenuloplasty) or without (frenotomy/frenulectomy).^[@bibr5-2473974X19826943][@bibr6-2473974X19826943]-[@bibr7-2473974X19826943]^ However, there are no accepted guidelines on management of ankyloglossia. Few studies examined the relationship between ankyloglossia and speech impairments, but they reported conflicting results. The objectives of our study are to determine speech and language outcomes among patients with ankyloglossia who are undergoing frenulectomy and to identify factors contributing to the success of frenulectomy.

Methods {#section1-2473974X19826943}
=======

After Institutional Review Board approval (DUCOM 1802006100) was obtained, a retrospective chart review was conducted to identify patients who underwent lingual frenulectomy for ankyloglossia-related speech and language concerns from July 2012 to June 2017. Data were collected on patient age, sex, chief complaint, medial history, surgical history, physical examination, and method of ankyloglossia treatment. Patients were included in the study if they were \<18 years of age, presented with speech concerns related to ankyloglossia, and underwent frenulectomy. Severity of speech impairment was recorded pre- and postoperatively by the evaluating provider as mild, mild to moderate, moderate, moderate to severe, or severe. There were 4 providers in the study who were board certified in otolaryngology, and a chi-square analysis was done to determine if there was a difference in provider-assigned severity. Binary outcome variables were created per symptom improvement and a decrease in severity. Individual descriptive variables were tested with chi-square analysis for statistical relationships to improvements in postfrenulectomy speech. Data were entered into Microsoft Office Excel spreadsheets and exported to SPSS 25 (IBM, Armonk, New York) for analysis.

Results {#section2-2473974X19826943}
=======

A total of 188 patients were initially identified with speech and language concerns related to ankyloglossia who underwent frenulectomy. Forty-eight patients were followed up postoperatively and included in the study. The mean age was 2.86 years at initial evaluation, with 72% being male. Fifteen (28%) children were concurrently enrolled in speech and language therapy. There was no difference in assigned preoperative severity among the 4 providers (data not shown).

Children with preoperative moderate and moderate-to-severe speech and language impairment attained better speech and language outcomes after frenulectomy when compared with children with preoperative mild and mild-to-moderate speech and language impairment (100% vs 82%, *P* = .015). Patients who underwent sutured closure experienced better improvements in speech and language than did unsutured patients (100% vs 83%, *P* = .033). Additionally, patients who experienced readhesion of the frenulum had less improvements in speech and language (50% vs 78%, *P* = .045). Only 2 patients experienced readhesion, both of whom underwent frenulectomy without sutured closure. Age, sex, concurrent speech therapy, a combined procedure (ie, with myringotomy tube placement or adenotonsillectomy), and the presence of cognitive/developmental delay were not significant predictors of surgical success ([**Table 1**](#table1-2473974X19826943){ref-type="table"}).

###### 

Demographics and Clinical Characteristics of Patients Who Underwent Lingual Frenulectomy for Ankyloglossia-Related Speech and Language Impairment.

![](10.1177_2473974X19826943-table1)

                                                                                         No Symptom Improvement   Symptom Improvement   *P* Value
  -------------------------------------------------------------------------------------- ------------------------ --------------------- -------------------------------------------------------------
  Sex                                                                                                                                   .098
   Male                                                                                  2                        36                    
   Female                                                                                3                        12                    
  Age, y                                                                                                                                .256
   \<2                                                                                   1                        11                    
   2-5                                                                                   2                        31                    
   \>5                                                                                   2                        6                     
  Preoperative symptom severity^[a](#table-fn1-2473974X19826943){ref-type="table-fn"}^                                                  .015^[b](#table-fn2-2473974X19826943){ref-type="table-fn"}^
   Mild                                                                                  4                        8                     
   Mild to moderate                                                                      0                        10                    
   Moderate                                                                              0                        29                    
   Moderate to severe                                                                    0                        1                     
   Severe                                                                                0                        0                     
  Sutured closure                                                                                                                       .033^[b](#table-fn2-2473974X19826943){ref-type="table-fn"}^
   Yes                                                                                   0                        24                    
   No                                                                                    5                        24                    
  Concurrent speech therapy                                                                                                             .542
   Yes                                                                                   2                        13                    
   No                                                                                    3                        35                    
  Combined procedure                                                                                                                    .401
   Yes                                                                                   0                        6                     
   No                                                                                    5                        42                    
  Developmental/cognitive delay                                                                                                         .520
   Yes                                                                                   1                        5                     
   No                                                                                    4                        34                    
  Readhesion                                                                                                                            .045^[b](#table-fn2-2473974X19826943){ref-type="table-fn"}^
   Yes                                                                                   1                        1                     
   No                                                                                    4                        47                    

Preoperative symptom severity was defined by the physician in the chart at the initial encounter.

*P* \< .05.

Discussion {#section3-2473974X19826943}
==========

Ankyloglossia is a common congenital anomaly that can restrict tongue mobility and cause limitations among children, such as feeding and speech difficulties.^[@bibr1-2473974X19826943][@bibr2-2473974X19826943][@bibr3-2473974X19826943]-[@bibr4-2473974X19826943]^ Many experts recommend surgical intervention owing to the ease of operation and low complication rates. However, there are no universally accepted guidelines regarding the treatment for ankyloglossia. Several studies documented improved breastfeeding after frenulectomy in children.^[@bibr8-2473974X19826943][@bibr9-2473974X19826943]-[@bibr10-2473974X19826943]^ However, only a few studies examined the efficacy of surgery for children with speech concerns related to ankyloglossia. One study determined that parents of neonates reported improved speech outcomes and tongue mobility after surgery as compared with neonates whose parents declined surgery for ankyloglossia.^[@bibr11-2473974X19826943]^ Another study found similar results and determined that tongue mobility, protrusion, and speech improved among children after frenotomy.^[@bibr12-2473974X19826943]^ On the contrary, other studies suggested that tongue division surgery does not improve articulation and speech among children.^[@bibr13-2473974X19826943],[@bibr14-2473974X19826943]^ These conflicting results leave providers with unanswered strategies for the management of ankyloglossia.

Our study demonstrated that patients with moderate and moderate-to-severe speech and language impairments experience greater symptom improvements from frenulectomy when compared with patients with mild and mild-to-moderate impairments. Additionally, patients in our study who underwent sutured closure experienced better speech and language improvements than did those not sutured after frenulectomy.

The results of our study should be interpreted within the context of certain limitations. Our study was retrospective, which can result in incomplete and variable data. Specifically, 188 patients were initially screened, with follow-up data on only 48 patients. Patients who improved may not have followed up, which can create selection bias by leaving the most severe patients for analysis. However, this can be attributed to the poor follow-up of our patient population due to a variety of factors, namely socioeconomic. Several providers evaluated the patients; therefore, the grading of speech and language impairments could be variable. However, upon further examination, there was no difference in assigned preoperative severity among the 4 providers. Furthermore, providers graded only the severity of speech and language impairment rather than the degree of ankyloglossia. The results of this study were demonstrated in a small sample size. Despite this, our study showed that surgical intervention may not always be indicated for children with mild or mild-to-moderate speech and language concerns related to ankyloglossia. In our study, we attempted to associate sutured closure with readhesion of the frenulum. Patients who underwent sutured closure experienced better speech and language improvements postoperatively. Although 2 unsutured patients experienced readhesion, this is too small of a sample size to make a conclusion regarding sutured closure preventing readhesion and subsequent lack of speech improvements. Therefore, our results should be viewed as hypothesis generating rather than conclusive.

Conclusion {#section4-2473974X19826943}
==========

Ultimately, it appears that surgical intervention does improve speech outcomes for children with greater severity of symptoms. Future prospective studies with larger sample sizes are encouraged, particularly ones that objectively grade the severity of ankyloglossia. This will help to surgically stratify cases of ankyloglossia.
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